Immunomodulatory activity

  • Lee Chong Kil 

4.7.4. Conclusion

There have been numerous reports demonstrating that polysaccharides contained in the gel of aloe species exhibit immunomodulatory activity in vivo as well as in vitro. Studies on the efficacy and toxicity of the aloe polysaccharides have even lead to the development of an injectable form of polysaccharide, acemannan (CARN 750). The mechanisms for the immunomodulatory activity has become clearer in recent years. The fact that acemannan induces phenotypic and functional maturation of immature DCs has an important implication in understanding the antiviral and antitumoral activities of acemannan, because it has been well-documented that DCs are the most important accessory cells for the activation of naïve T cells and generation of primary T cell responses. Although there is a general consensus on the diverse immunomodulatory activities of the polysaccharide fraction isolated from aloe gel, the optimal molecular size exhibiting maximum immuno-modulatory activity has been a matter of debate. Optimal molecular size exhibiting maximal immunomodulating activity may vary depending on the examination parameters for the immunomodulatory activities. Examination of the molecular size-activity relationship showed that polysaccharides between 5 – 400 KDa exhibit the most potent immunomodulatory activity. The fact that MAP smaller than 400 KDa exhibits potent immunomodulatory activity has important implications, because, for in vivo applications, smaller MW molecules are usually preferred to higher MW molecules due to bioavailability issues. Further studies using different in vivo systems are still required to establish the molecular size-activity relationship more clearly, and this type of study would be essential to develop aloe polysaccharides as therapeutic drugs.


Feline Immunodeficiency Virus Immunomodulatory Activity Aloe Barbadensis Aloe Species Allogeneic Mixed Lymphocyte Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, and Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767–811.PubMedCrossRefGoogle Scholar
  2. 2.
    Byeon SW, Pelley RP, Ullrich SE, Waller TA, Bucana CD, and Strickland FM (1998) Aloe barbadensis extracts reduce the production of interleukin-10 after exposure to ultraviolet radiation J Invest Dermatol 110: 811–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Chinnah AD, Baig MA, Tizard IR, and Kemp MC (1992) Antigen dependent adjuvant activity of a polydispersed beta-(1.4)-linked acetylated mannan (acemannan) Vaccine 10: 551–557.PubMedCrossRefGoogle Scholar
  4. 4.
    Djeraba A., and Quere P (2000). In vivo macrophage activation in chickens with Acemannan, a complex carbohydrate extracted from Aloe vera Int J Immunopharmacol 22: 365–372.PubMedCrossRefGoogle Scholar
  5. 5.
    Egger S, Brown GS, Kelsey LS, Yates KM, Rosenberg LJ, and Talmadge JE (1996a) Studies on optimal dose and administration schedule of a hematopoietic stimulatory-(1,4)-linked mannan Int J Immunopharmacol 18: 113–126.PubMedCrossRefGoogle Scholar
  6. 6.
    Egger S, Brown GS, Kelsey LS, Yates KM, Rosenberg LJ, and Talmadge JE (1996b) Hematopoietic augmentation by a beta-(1,4)-linked mannan Cancer Immunol Immunother 43: 195–205.PubMedCrossRefGoogle Scholar
  7. 7.
    Farkas A, and Mayer RA (1968) Polysaccharide from the juice of the aloe plant for treatment of wounds U.S. Patent 3,362,951.Google Scholar
  8. 8.
    Farkas A (1967) Methylated polysaccharide and method of making. US Patent, 3,360,510. Fujita, K., Suzuki, I., Ochiai, J., Shinpo, K., Inoue, S., and Saito, H. 1978. Specific reaction of aloe extract with serum proteins of various animals Experientia 34: 523–524.Google Scholar
  9. 9.
    Gowda DC, Neelisiddaiah B, Anjaneyalu YV (1979) Structural studies of polysaccharides from Aloe vera Carbohyd Res 72: 201–205.CrossRefGoogle Scholar
  10. 10.
    Green P (1996) Aloe vera extracts in equine clinical practice. Veterinary Times 26: 16–18 Haq Q.H. and Hannan A 1981 Studies on glucogalactomannan from the leaves of Aloe vera, Tourn.(ex Linn). Bangladesh J Sci Indus Res 16: 68–72.Google Scholar
  11. 11.
    Harris C, Pierce K, King G, Yates KM, Hall J, Tizard I (1991) Efficacy of acemannan in treatment of canine and feline spontaneous neoplasms Molec Biother 3: 207–213.Google Scholar
  12. 12.
    Im AA, Oh ST, Song S, Kim MR, Kim DS, Woo SS, Jo TH, Park YI, Lee CK (2005) Identification of optimal molecular size of modified Aloe polysaccharides with maximum immunomodulatory activity Int Immunopharmacol 5: 271–279.PubMedCrossRefGoogle Scholar
  13. 13.
    Imanishi K (1993) Aloctin A, an active substance of Aloe arborescens Miller as an immunomodulator Phytother Res 7: S20–S22.Google Scholar
  14. 14.
    Imanishi K, Ishiguro T, Saito H, and Suzuki I (1981) Pharmacological studies on a plant lectin, Aloctin A. I. Growth inhibition of mouse methylcholanthrene induced fibrosarcoma (Meth A) in ascites form by Aloctin A Experientia 37: 1186–1187.PubMedCrossRefGoogle Scholar
  15. 15.
    Imanishi K, and Suzuki I (1984) Augmentation of natural cell-mediated cytotoxic reactivity of mouse lymphoid cells by Aloctin A Int J Immunopharmacol 6: 539–543.PubMedCrossRefGoogle Scholar
  16. 16.
    Imanishi K, and Suzuki I (1986) Induction of nonspecific cell mediated cytotoxic reactivity from non-immune spleen cells treated with Aloctin A Int J Immunopharmacol 8: 781–787.PubMedCrossRefGoogle Scholar
  17. 17.
    Imanishi K, Tsukuda K, and Suzuki I (1986) Augmentation of lymphokine-activated killer cell activity in vitro by Aloctin A Int J Immunopharmacol 8: 855–858.PubMedCrossRefGoogle Scholar
  18. 18.
    Karaca K, Sharma JM, and Nordgren R (1995) Nitric oxide production by chicken macrophages activated by acemannan, a complex carbohydrate extracted from Aloe vera Int J Immunopharmacol 17: 183–188.PubMedCrossRefGoogle Scholar
  19. 19.
    King GK, Yates KM, Greenlee PG, Pierce KR, Ford CR, McAnalley BH, Tizard IR (1995) The effects of acemannan immunostimulant in combination with surgery and radiation therapy on spontaneous canine and feline fibrosarcomas J Am Anim Hosp Assoc 31: 439–447.PubMedGoogle Scholar
  20. 20.
    Lee JK, Lee MK, Yun YP, Kim Y, Kim JS, Kim YS, Kim K, Han SS, Lee CK (2001) Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells Int Immunopharmacol 1: 1275–1284.PubMedCrossRefGoogle Scholar
  21. 21.
    Mandal G, Das A (1980) Structure of the glucomannan isolated from the leaves of Aloe barbadensis Miller Carbohyd Res 87: 249–256.CrossRefGoogle Scholar
  22. 22.
    Madis VH, Omar MM, Madi SV (1989) Aloeferon isolation, manufacturing and its applications U.S. Patent 4,861,761.Google Scholar
  23. 23.
    Manna S, McAnalley BH (1993) Determination of the position of the O acetyl group in β-(1-4) mannan (acemannan) from Aloe barbadensis Miller. Carbohyd Res 241: 317–319.CrossRefGoogle Scholar
  24. 24.
    Marshall GD, Druck JP (1993) In vitro stimulation of NK activity by acemannan J Immunol 150: 241A.Google Scholar
  25. 25.
    Marshall GD, Gibbons AS, Parnell LS (1993) Human cytokines induced by acemannan J Allergy and Clin Immunol 91: 295.Google Scholar
  26. 26.
    McAnalley BH, McDaniel HR, Carpenter RH (1988) Demonstration of in vitro antiviral action of acemannan (ACE-M) against multiple viruses including the HIV virus Proceedings of the IV International Conference on AIDS p158.Google Scholar
  27. 27.
    Nordgren RM, Stewart-Brown B, Rodeberg JH (1992) The role of acemannan as an adjuvant for Marek’s disease vaccine Proceedings of the XIX Worlds Poultry Congress 165–169.Google Scholar
  28. 28.
    Peng SY, Norman J, Curtin G, Corrier D, McDaniel HR, Busbee D (1991) Decreased mortality of Norman Murine Sarcoma in mice treated with the immunomodulator Acemannan Mol Biother 3: 79–87.Google Scholar
  29. 29.
    Pugh N, Ross SA, EiSohly MA, Pasco DS (2001) Characterization of aloeride a new polysaccharide from Aloe vera with potent immunostimulatory activity J Agric Food Chem 49: 1030–1034.PubMedCrossRefGoogle Scholar
  30. 30.
    Qui Z, Jones K, Wylie M, Jia Q, Orndorff S (2000) Modified Aloe barbadensis polysaccharide with immunomodulatory activity Planta Med 66: 152–156.CrossRefGoogle Scholar
  31. 31.
    Ramamoorthy L, Kemp M.C, Tizard IR (1996) Acemannan, a-(1,4)-acetylated mannan, induces nitric oxide production in macrophage cell line Raw 264 7 Mol Pharmacol 50: 878–884.PubMedGoogle Scholar
  32. 32.
    Ramamoorthy L, Tizard IR (1988) Induction of apoptosis in a macrophage cell line RAW 264.7 by acemannan, a-(1,4)-acetylated mannan. Mol Pharmacol 53: 415–421.Google Scholar
  33. 33.
    Reynolds T, Dweck AA (1999) Aloe vera gel leaf: a review update J Ethnopharmacol 68: 3–37.PubMedCrossRefGoogle Scholar
  34. 34.
    Saito H, Ishiguro T, Imanishi K, Suzuki I (1982) Pharmacological studies on a plant lectin aloctin A. II. Inhibitory effect of aloctin A on experimental models of inflammation in rats Jpn J Pharmacol 32: 139–142.PubMedGoogle Scholar
  35. 35.
    Sharma JM, Karaca K, Pertile T (1994) Virus-induced immunosuppression in chickens Poultry Sci 73: 1082–1086.Google Scholar
  36. 36.
    Sheets MA, Unger BA, Giggleman GR. Jr, Tizard IR (1991) Studies of the effect of acemannan on retrovirus infections: Clinical stabilization of feline leukemia virus-infected cats Mol Biother 3: 41–45.PubMedGoogle Scholar
  37. 37.
    Strickland FM, Pelley RP, Kripke ML (1994) Prevention of ultraviolet radiation-induced suppression of contact and delayed hypersensitivity by Aloe barbadensis gel extract J Invest Dermatol 102: 197–204.PubMedCrossRefGoogle Scholar
  38. 38.
    Stuart RW, Lefkowitz DL, Lincoln JA, Howard K, Gelderman MP, Lefkowitz SS (1997) Upregulation of phagocytosis and candidacidal activity of macrophages exposed to the immunostimulant acemannan Int J Immunopharmacol 19: 75–82.PubMedCrossRefGoogle Scholar
  39. 39.
    Stuart RW, Lefkowitz DL, Lincoln JA, Howard K, Gelderman MP, Lefkowitz SS (1997) Upregulation of phagocytosis and candidacidal activity of macrophages exposed to the immunostimulant, acemannan Int J Immunopharmacol. 19: 75–82.PubMedCrossRefGoogle Scholar
  40. 40.
    Talmadge J, Chavez J, Jacobs L, Munger C, Chinnah T, Chow JT, Williamson D, Yates K (2004) Fractionation of Aloe vera L. inner gel, purification and molecular profiling of activity Int Immunopharmacol 4: 1757–1773.PubMedCrossRefGoogle Scholar
  41. 41.
    Tietze C, Schlesinger PH, and Stahl P (1982) Mannose-specific endocytosis receptor of alveolar macrophages: demonstration of two functionally distinct intracellular pools of receptor and their roles on receptor cycling J Cell Biol 92: 417–424.PubMedCrossRefGoogle Scholar
  42. 42.
    Tizard I, Carpenter RH, Kemp M (1991) Immunoregulatory effects of a cytokine release enhancer (Acemannan). International Congress of Phytotherapy 1991 Seoul Korea p68.Google Scholar
  43. 43.
    Usinger WR (1997) A comparison of antibody responses to veterinary vaccine antigens potentiated by different adjuvants Vaccine 15: 1902–1907.PubMedCrossRefGoogle Scholar
  44. 44.
    Womble D, Helderman JH (1988) Enhancement of allo-responsiveness of human lymphocytes by acemannan (Carrisyn) Int J Immunopharmacol 10: 967–973.PubMedCrossRefGoogle Scholar
  45. 45.
    Womble D, Helderman JH (1992) The impact of acemannan on the generation and function of cytotoxic T-lymphocytes Immunopharmacol Immunotoxicol 14: 63–77.PubMedGoogle Scholar
  46. 46.
    Yagi A, Makino K, Nishioka I, Kuchino Y (1977) Aloe mannan, polysaccharide from Aloe arborescens var natalensis Planta med 31: 17–20.PubMedCrossRefGoogle Scholar
  47. 47.
    Yates KM, Rosenberg LJ, Harris CK, Bronstad DC, King GK, Biehle GA, Walker B, Ford CR, Hall JE, Tizard IR (1992) Pilot study of the effect of acemannan in cats infected with feline immunodeficiency virus Vet Immunol Immunopathol 35: 177–189.PubMedCrossRefGoogle Scholar
  48. 48.
    Zhang L, Tizard IR (1996) Activation of a mouse macrophage cell line by acemannan: the major carbohydrate fraction from Aloe vera gel Immunopharmacol 35: 119–128.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Lee Chong Kil 
    • 1
  1. 1.College of PharmacyChungbuk National UniversityCheongju, ChungbukKorea

Personalised recommendations